Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Therapeutics × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Breast Neoplasms 3 Thyroid Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Depression 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Smoking Cessation 1 Sezary Syndrome 1 Pyloric Stenosis, Hypertrophic 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pain 1 Ovariancancer 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1

Interventions

Cyclophosphamide 11 fludarabine 10 fludarabine phosphate 8 asciminib 7 Whole-Body Irradiation 7 Mycophenolic Acid 7 Tacrolimus 6 Melphalan 5 Busulfan 5 nilotinib 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Dasatinib 4 Imatinib Mesylate 3 Filgrastim 3 olverembatinib 2 bosutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ruxolitinib 1 ponatinib 1 blinatumomab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡